NanoViricides
NNVC
#10430
Rank
S$48.49 M
Marketcap
S$1.90
Share price
-2.30%
Change (1 day)
-7.07%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$1.36 Million

According to NanoViricides's latest financial reports the company's total liabilities are S$1.36 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30S$1.66 M-9.81%
2024-06-30S$1.84 M-33.08%
2023-06-30S$2.75 M379.27%
2022-06-30S$0.57 M21.54%
2021-06-30S$0.47 M-84.29%
2020-06-30S$3 M-21.94%
2019-06-30S$3.85 M220.31%
2018-06-30S$1.2 M-86.93%
2017-06-30S$9.19 M-49.75%
2016-06-30S$18.3 M9.53%
2015-06-30S$16.7 M-34.59%
2014-06-30S$25.54 M139.71%
2013-06-30S$10.65 M372.61%
2012-06-30S$2.25 M212.93%
2011-06-30S$0.72 M-79.02%
2010-06-30S$3.43 M361.09%
2009-06-30S$0.74 M-46.57%
2008-06-30S$1.39 M6.95%
2007-06-30S$1.3 M-45.07%
2006-06-30S$2.37 M2023.58%
2005-06-30S$0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
S$42.07 B 3,082,938.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$105.99 B 7,767,238.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$85.01 B 6,229,802.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$77.08 B 5,649,058.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S$1.52 B 111,398.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.30 B 95,533.61%๐Ÿ‡บ๐Ÿ‡ธ USA